Global Molecular Diagnostics Market

Global Molecular Diagnostics Market 2023-2027

The molecular diagnostics market is forecasted to grow by USD 7,722.71 mn during 2022-2027, accelerating at a CAGR of 5.96% during the forecast period. The report on the molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of age-related diseases, global adoption of advanced treatment solutions, and high demand from developing countries.

Technavio's molecular diagnostics market is segmented as below:

By Product

• Instruments
• Reagents
• kits

By Application

• Infectious disease
• Oncology
• Blood screening
• Microbiology
• Others

By Geographical Landscape

• Asia
• Europe
• North America
• Rest of World (ROW)

This study identifies the integration of next-generation sequencing (NGS) as one of the prime reasons driving the molecular diagnostics market growth during the next few years. Also, mergers and acquisitions among players and expanding the healthcare industry will lead to sizable demand in the market.

The report on the molecular diagnostics market covers the following areas:

• Molecular diagnostics market sizing
• Molecular diagnostics market forecast
• Molecular diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., ELITechGroup SAS , F. Hoffmann La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic Inc., Illumina Inc., QIAGEN NV, Siemens Healthineers AG, SOLONE LIFE SCIENCES INDIA PVT LTD., Spectrum Diagnostics and Health Care, Sysmex Corp., Thermo Fisher Scientific Inc., U GEN BIOTECHNOLOGY INC, and Xiamen Zeesan Biotech Co. Ltd.. Also, the molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.